Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Saved in:
| Title: | Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. |
|---|---|
| Authors: | Vermij L; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Jobsen JJ; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands., León-Castillo A; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Brinkhuis M; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., Roothaan S; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., Powell ME; Department of Clinical Oncology, Barts and The London NHS Trust, London, UK., de Boer SM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Khaw P; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Mileshkin LR; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Fyles A; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Genestie C; Department of Pathology, Gustave Roussy, Villejuif, France., Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Crosbie EJ; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, UK.; Department of Obstetrics and Gynaecology, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Mackay HJ; Department of Medical Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Nijman HW; Department of Gynaecology, University Medical Center Groningen, Groningen, The Netherlands., Nout RA; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Smit VTHBM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Horeweg N; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. T.Bosse@lumc.nl. |
| Corporate Authors: | TransPORTEC Consortium |
| Source: | British journal of cancer [Br J Cancer] 2023 Mar; Vol. 128 (7), pp. 1360-1368. Date of Electronic Publication: 2023 Jan 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36690721 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vermij+L%22">Vermij L</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jobsen+JJ%22">Jobsen JJ</searchLink>; Department of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22León-Castillo+A%22">León-Castillo A</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brinkhuis+M%22">Brinkhuis M</searchLink>; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Roothaan+S%22">Roothaan S</searchLink>; Department of Pathology, Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Powell+ME%22">Powell ME</searchLink>; Department of Clinical Oncology, Barts and The London NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22de+Boer+SM%22">de Boer SM</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Khaw+P%22">Khaw P</searchLink>; Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Mileshkin+LR%22">Mileshkin LR</searchLink>; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Fyles+A%22">Fyles A</searchLink>; Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Leary+A%22">Leary A</searchLink>; Department of Medical Oncology, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Genestie+C%22">Genestie C</searchLink>; Department of Pathology, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Jürgenliemk-Schulz+IM%22">Jürgenliemk-Schulz IM</searchLink>; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Crosbie+EJ%22">Crosbie EJ</searchLink>; Gynaecological Oncology Research Group, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St. Mary's Hospital, Manchester, UK.; Department of Obstetrics and Gynaecology, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Mackay+HJ%22">Mackay HJ</searchLink>; Department of Medical Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Nijman+HW%22">Nijman HW</searchLink>; Department of Gynaecology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nout+RA%22">Nout RA</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+VTHBM%22">Smit VTHBM</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Creutzberg+CL%22">Creutzberg CL</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Horeweg+N%22">Horeweg N</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bosse+T%22">Bosse T</searchLink>; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. T.Bosse@lumc.nl. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22TransPORTEC+Consortium%22">TransPORTEC Consortium</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2023 Mar; Vol. 128 (7), pp. 1360-1368. <i>Date of Electronic Publication: </i>2023 Jan 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36690721 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-023-02141-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1360 Titles: – TitleFull: Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vermij L – PersonEntity: Name: NameFull: Jobsen JJ – PersonEntity: Name: NameFull: León-Castillo A – PersonEntity: Name: NameFull: Brinkhuis M – PersonEntity: Name: NameFull: Roothaan S – PersonEntity: Name: NameFull: Powell ME – PersonEntity: Name: NameFull: de Boer SM – PersonEntity: Name: NameFull: Khaw P – PersonEntity: Name: NameFull: Mileshkin LR – PersonEntity: Name: NameFull: Fyles A – PersonEntity: Name: NameFull: Leary A – PersonEntity: Name: NameFull: Genestie C – PersonEntity: Name: NameFull: Jürgenliemk-Schulz IM – PersonEntity: Name: NameFull: Crosbie EJ – PersonEntity: Name: NameFull: Mackay HJ – PersonEntity: Name: NameFull: Nijman HW – PersonEntity: Name: NameFull: Nout RA – PersonEntity: Name: NameFull: Smit VTHBM – PersonEntity: Name: NameFull: Creutzberg CL – PersonEntity: Name: NameFull: Horeweg N – PersonEntity: Name: NameFull: Bosse T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2023 Mar Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 128 – Type: issue Value: 7 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |